Efficacy of intravenous glutathione vs. placebo for skin tone lightening
Keywords:
Taylor hyperpigmentation scale, glutathione, anaphylaxis, skin toneAbstract
Objective To evaluate the efficacy and possible side effects of intravenous glutathione used for lightening the skin tone.Methods This placebo-controlled study was conducted in department of dermatology, City Hospital, Multan from January 2014 to August 2015. Out of 50 enrolled patients 32 patients completed the study. All patients were females with age ranging from 25 to 47 years. In group A, 8 patients had deranged liver function tests and one patient who developed anaphylactic shock were excluded from study along with their controls from group B. Final results were concluded in only those patients who completed the study. 32 patients were treated in two groups (A & B). In group A 16 patients were given intravenous glutathione and vitamin C. Patients in group B were given intravenous normal saline as placebo. Taylor hyperpigmentation scale was used to measure the skin tone. Two body sites, which were non-exposed to sun, were measured with Taylor hyperpigmentation cards. Injection GSH Detox forte 1200 mg (aqua, glutathione 1200 mg, ascorbic acid, hydrolyzed collagen 35 mg and sodium chloride) was given. Two injections per week for 6 weeks (total of 12 injections) were given. The effectiveness and side effects were assessed at the end of therapy and 2 months, 4 months and 6 months after cessation of treatment.Results After 12 injections of glutathione, 6 of 16 (37.5%) subjects showed significant improvement, whereas 3 (18.7%) subjects improved with placebo (p = 0.054). After stopping the treatment, this improvement was gradually lost and at six-month posttreatment follow-up only one patient maintained this improvement. Adverse effects were noted in all subjects. Severe adverse effects warranting discontinuation of treatment were deranged liver function tests (n=8) and patient anaphylaxis (n=1).Conclusion Glutathione is not very effective for skin tone lightening; moreover treatment loses its efficacy with time. The side effects of the treatment are common.References
Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: A randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012;23:97-102.
Villarama CD, Maibach HI. Glutathione as depigmenting agent: an overview. Int J Cosmet Sci. 2005;27:147-53.
Meister A, Anderson A. Glutathione. Annu Rev Biochem. 1983;52:711-60.
Handog EB, Datuin MS, Singzon IA. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. Int J Dermatol. 2016;55:153-7.
Molinar VE, Taylor SC, Pandya AG. What’s new in objective assessment and treatment of facial hyperpigmentation? Dermatol Clin. 2014;32:123-35.
Handog EB, Datuin S, Singzon IA, Castillo JC. Glutathione as a systemic skin whitening agent via buccal mucosa: an open label, single-arm study. American Academy of Dermatology 2016. poster 3390.
Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988;263:17205-8.
Dickinson DA. Forman HJ. Glutathione in defense and signaling: Lessons from a small thiol. Ann N Y Acad Sci. 2002;973:488-504.
Exner R, Wessner B, Manhart N, Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr. 2000;112:610-6.
Yun IS, Lee WJ, Rah DK, Kim YO, Park BY. Skin color analysis using a spectrophotometer in Asians. Skin Res Technol. 2010;16:311-5.
Clarys P, Alewaeters K, Lambrecht R, Barel AO. Skin color measurements: comparison between three instruments: the Chromameter (R), the DermaSpectrometer (R) and the Mexameter (R). Skin Res Technol. 2000;6:230-8.
Taylor S, Westerhof W, Im S, Lim J. Noninvasive techniques for the evaluation of skin color. J Am Acad Dermatol. 2006;54:282-90.
Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. Clin Cosmet Investig Dermatol. 2014;17;7:267-74.
14Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489-92.
Hauser RA, Lyons KE, McClain T et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009;24:979-83.
Franco RSO, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human disease. Arch Physiol Biochem. 2007;113:234-58.
Smirnoff N. L-ascorbic acid biosynthesis. Vitam Horm. 2001;61:241-66.
